(Q36794149)

16 August 2017

1 reference

title

Efficacy of various intravenous immunoglobulin therapy protocols in autoimmune and chronic inflammatory disorders (English)

1 reference

16 August 2017

Hakan M Gürcan

1

1 reference

16 August 2017

A Razzaque Ahmed

series ordinal

2

1 reference

16 August 2017

language of work or name

English

0 references

publication date

17 April 2007

1 reference

Annals of Pharmacotherapy

16 August 2017

published in

1 reference

16 August 2017

volume

41

1 reference

16 August 2017

issue

5

1 reference

16 August 2017

page(s)

812-823

1 reference

Use of intravenous immunoglobulin in human disease: a review of evidence by members of the Primary Immunodeficiency Committee of the American Academy of Allergy, Asthma and Immunology

16 August 2017

cites work

1 reference

21 January 2018

1 reference

Treatment of immune thrombocytopenic purpura in children : current concepts.

21 January 2018

1 reference

Corticosteroids versus intravenous immune globulin for the treatment of acute immune thrombocytopenic purpura in children: a systematic review and meta-analysis of randomized controlled trials

21 January 2018

1 reference

Treatment of Guillain-Barré syndrome and CIDP.

21 January 2018

1 reference

21 January 2018

Guillain-Barré syndrome

1 reference

The use of intravenous immunoglobulin in the treatment of autoimmune neuromuscular diseases: evidence-based indications and safety profile

21 January 2018

1 reference

Practice parameter: Immunotherapy for Guillain-Barre syndrome: Report of the Quality Standards Subcommittee of the American Academy of Neurology

21 January 2018

1 reference

Intravenous immune globulins in patients with Guillain-Barré syndrome and contraindications to plasma exchange: 3 days versus 6 days

21 January 2018

1 reference

Intravenous immunoglobulin treatment in autoimmune neurological disorders--effects on quality of life

21 January 2018

1 reference

Intravenous immunoglobulin for multifocal motor neuropathy

21 January 2018

1 reference

How long is IVIg effective in multifocal motor neuropathy?

21 January 2018

1 reference

European Federation of Neurological Societies/Peripheral Nerve Society guideline on management of multifocal motor neuropathy

21 January 2018

1 reference

Intravenous immunoglobulins in the treatment of relapsing remitting multiple sclerosis--results of a retrospective multicenter observational study over five years

21 January 2018

1 reference

Intravenous immunoglobulin treatment in multiple sclerosis. Effect on relapses.

21 January 2018

1 reference

No difference in efficacy of two different doses of intravenous immunoglobulins in MS: clinical and MRI assessment.

21 January 2018

1 reference

IV immunoglobulin does not reverse established weakness in MS.

21 January 2018

1 reference

Intravenous immunoglobulin in secondary progressive multiple sclerosis: randomised placebo-controlled trial.

21 January 2018

1 reference

Intravenous immunoglobulin G for the treatment of relapsing-remitting multiple sclerosis: a meta-analysis

21 January 2018

1 reference

Intravenous immunoglobulin in autoimmune neuromuscular diseases

21 January 2018

1 reference

European Federation of Neurological Societies/Peripheral Nerve Society guideline on management of paraproteinaemic demyelinating neuropathies: report of a joint task force of the European Federation of Neurological Societies and the Peripheral Nerve

21 January 2018

1 reference

Dermatomyositis and Polymyositis

21 January 2018

1 reference

Treatment of idiopathic inflammatory myopathies

21 January 2018

1 reference

A controlled trial of high-dose intravenous immune globulin infusions as treatment for dermatomyositis

21 January 2018

1 reference

Therapeutic approaches in patients with inflammatory myopathies

21 January 2018

1 reference

The stiff-person syndrome: an autoimmune disorder affecting neurotransmission of gamma-aminobutyric acid

21 January 2018

1 reference

Pathogenesis of graves ophthalmopathy: implications for prediction, prevention, and treatment

21 January 2018

1 reference

Systemic lupus erythematosus: 2006 update

21 January 2018

1 reference

A study of 20 SLE patients with intravenous immunoglobulin--clinical and serologic response

21 January 2018

1 reference

Successful treatment of systemic lupus erythematosus cerebritis with intravenous immunoglobulin

21 January 2018

1 reference

Intravenous immunoglobulin treatment of lupus nephritis

21 January 2018

1 reference

Intravenous immunoglobulin therapy and systemic lupus erythematosus

21 January 2018

1 reference

Stevens-Johnson syndrome and toxic epidermal necrolysis: a review of the literature

21 January 2018

1 reference

Use of intravenous immunoglobulin in toxic epidermal necrolysis and Stevens-Johnson syndrome: our current understanding

21 January 2018

1 reference

Treatment of epidermal necrolysis with high-dose intravenous immunoglobulins (IV Ig): clinical experience to date

21 January 2018

1 reference

Consensus statement on the use of intravenous immunoglobulin therapy in the treatment of autoimmune mucocutaneous blistering diseases

21 January 2018

1 reference

Analysis of current data on the use of intravenous immunoglobulins in management of pemphigus vulgaris

21 January 2018

1 reference

Intravenous immunoglobulin therapy in the treatment of patients with pemphigus vulgaris unresponsive to conventional immunosuppressive treatment

21 January 2018

1 reference

Corticosteroid-sparing effect of intravenous immunoglobulin therapy in patients with pemphigus vulgaris

21 January 2018

1 reference

The role of IVIg treatment in severe pemphigus vulgaris.

21 January 2018

1 reference

Effect of intravenous immunoglobulin on prednisone dose in patients with pemphigus vulgaris

21 January 2018

1 reference

Diagnostic features of pemphigus vulgaris in patients with pemphigus foliaceus: detection of both autoantibodies, long-term follow-up and treatment responses

21 January 2018

1 reference

Intravenous immunoglobulin therapy for patients with pemphigus foliaceus unresponsive to conventional therapy

21 January 2018

1 reference

Intravenous immunoglobulin therapy for ocular cicatricial pemphigoid: a preliminary study.

21 January 2018

1 reference

Intravenous immunoglobulin therapy in patients with multiple mucosal involvement in mucous membrane pemphigoid

21 January 2018

1 reference

Comparison between intravenous immunoglobulin and conventional immunosuppressive therapy regimens in patients with severe oral pemphigoid: effects on disease progression in patients nonresponsive to dapsone therapy

21 January 2018

1 reference

Treatment of oral pemphigoid with intravenous immunoglobulin as monotherapy. Long-term follow-up: influence of treatment on antibody titres to human alpha6 integrin

21 January 2018

1 reference

A nonrandomized comparison of the clinical outcome of ocular involvement in patients with mucous membrane (cicatricial) pemphigoid between conventional immunosuppressive and intravenous immunoglobulin therapies.

21 January 2018

1 reference

Intravenous immunoglobulin therapy for patients with bullous pemphigoid unresponsive to conventional immunosuppressive treatment

21 January 2018

1 reference

Adverse effects of intravenous immunoglobulin therapy in 56 patients with autoimmune diseases

21 January 2018

1 reference

Intravenous immunoglobulin: adverse effects and safe administration

21 January 2018

1 reference

Severe eczematous skin reaction after high-dose intravenous immunoglobulin infusion: report of 4 cases and review of the literature.

21 January 2018

1 reference

Acute renal failure and intravenous immune globulin: occurs with sucrose-stabilized, but not with D-sorbitol-stabilized, formulation

21 January 2018

1 reference

Intravenous immunoglobulin-associated acute renal failure: case series and literature review

21 January 2018

1 reference

Adverse events associated with intravenous immunoglobulin therapy

21 January 2018

1 reference

Complications of intravenous immune globulin treatment in neurologic disease

21 January 2018

1 reference

Clinical efficacy and safety of a novel intravenous immunoglobulin preparation in adult chronic ITP.

21 January 2018

1 reference

Side effects of intravenous immunoglobulins in neurological autoimmune disorders--a prospective study

21 January 2018

1 reference

Aseptic meningitis associated with high-dose intravenous immunoglobulin therapy: frequency and risk factors

21 January 2018

1 reference

Neurologic complications of treatment of childhood acute immune thrombocytopenic purpura with intravenously administered immunoglobulin G.

21 January 2018

1 reference

Intravenous immunoglobulin for cystic fibrosis lung disease: a case series of 16 children

21 January 2018

1 reference

A multicenter, randomized, double-blind, placebo-controlled trial of high-dose intravenous immunoglobulin for oral corticosteroid-dependent asthma.

21 January 2018

1 reference

Venous and arterial thrombosis following administration of intravenous immunoglobulins

21 January 2018

1 reference

Intravenous immunoglobulin-associated arterial and venous thrombosis; report of a series and review of the literature

21 January 2018

1 reference

Review: intravenous immunoglobulin therapy and thromboembolic complications

21 January 2018

1 reference

Treatment of inclusion-body myositis with IVIg: a double-blind, placebo-controlled study

21 January 2018

1 reference

A controlled study of intravenous immunoglobulin combined with prednisone in the treatment of IBM.

21 January 2018

1 reference

Clinical trial of plasma exchange and high-dose intravenous immunoglobulin in myasthenia gravis

21 January 2018

1 reference

Treatment of Myasthenia Gravis Exacerbation With Intravenous Immunoglobulin

21 January 2018

1 reference

21 January 2018

Identifiers

DOI

10.1345/APH.1K037

1 reference

16 August 2017

1 reference